Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Phase Maintenance Timing Daily Daily Dose 1.4 mg Notes Use immediately after mixing (per label)
Cagrilintide is an amylin-based peptide analogue designed to support appetite control, improve feelings of fullness, and assist with weight management
Women under 140 pounds typically respond well to 0.5mg daily, while those over 160 pounds may benefit from the full 1mg dose
GHK-Cu forms a complex with copper, which gives the reconstituted solution a characteristic blue tint
Key safety considerations include: Infection risk : Any injection carries risk of infection if proper aseptic technique is not followed Allergic reactions : Multiple ingredients increase the potential for hypersensitivity Undiagnosed conditions : Self-administration or private clinic use may delay diagnosis of underlying medical conditions Pregnancy and breastfeeding : Safety data for lipotropic formulations in pregnancy is lacking Call 999 immediately if you experience signs of anaphylaxis (difficulty breathing, facial/tongue swelling, collapse) after an injection
Studies in animal models have shown an anorexigenic action of GIP receptor agonism [36] and a recent phase 1 clinical trial with a long-acting GIP RA found that repeated dosing for 4 weeks induced modest WL (1.9 to 3.1 kg vs
US$ 21.34
US$ 26.83
US$ 20.74
